Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 6.14
-4.66 %
$ 201 M
Market Cap
-6.75
P/E
CASH FLOW STATEMENT
-27.2 M
OPERATING CASH FLOW
438 K
INVESTING CASH FLOW
752 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sera Prognostics, Inc.
| Net Income | -36.2 M |
| Depreciation & Amortization | 900 K |
| Capital Expenditures | -128 K |
| Stock-Based Compensation | 5.27 M |
| Change in Working Capital | 3.52 M |
| Others | 3.37 M |
| Free Cash Flow | -27.3 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (36.2) | (44.2) | (35.0) | (19.8) | (16.5) |
| Depreciation & Amortization | 0.9 | 0.8 | 0.7 | 0.9 | 0.9 |
| Deferred Income Tax | 0 | 0 | (1.1) | 0 | (0.1) |
| Stock Based Compensation | 5.3 | 5.1 | 3.1 | 0.7 | 0.4 |
| Other Operating Activities | (0.6) | 0.2 | 0.7 | 1.7 | (0.4) |
| Change in Working Capital | 3.5 | 3.6 | 44 K | (0.3) | (3.6) |
| Cash From Operations | (27.2) | (34.6) | (31.6) | (16.9) | (19.3) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.1) | (0.8) | (1.3) | (0.1) | (0.1) |
| Other Items | 0.6 | 6.3 | (81.3) | 0 | 0.1 |
| Cash From Investing Activities | 0.4 | 5.6 | (82.6) | (0.1) | 6 K |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (0.5) | (0.3) | (7.7) | (1.7) | 3.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.2 | 0.3 | 100.6 | 10.9 | 29.2 |
| Cash From Financing Activities | 0.8 | 5 K | 159.6 | 9.2 | 33.0 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (26.0) | (29.1) | 45.4 | (7.9) | 13.7 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (27.3) | (35.4) | (32.9) | (17.0) | (19.4) |